Isolated Growth Hormone Deficiency and Idiopathic Short Stature: Comparative Efficiency after Growth Hormone Treatment up to Adult Height
Introduction: Treatment with growth hormone (GH) is not approved for idiopathic short stature (ISS) in Europe. Objectives: To compare the growth of children treated with isolated GH deficiency (IGHD) vs. ISS-treated and untreated children. Methods: A retrospective descriptive study of patients treat...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4f881e7366af45fcbb92a7450b616b30 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:4f881e7366af45fcbb92a7450b616b30 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:4f881e7366af45fcbb92a7450b616b302021-11-11T17:37:08ZIsolated Growth Hormone Deficiency and Idiopathic Short Stature: Comparative Efficiency after Growth Hormone Treatment up to Adult Height10.3390/jcm102149882077-0383https://doaj.org/article/4f881e7366af45fcbb92a7450b616b302021-10-01T00:00:00Zhttps://www.mdpi.com/2077-0383/10/21/4988https://doaj.org/toc/2077-0383Introduction: Treatment with growth hormone (GH) is not approved for idiopathic short stature (ISS) in Europe. Objectives: To compare the growth of children treated with isolated GH deficiency (IGHD) vs. ISS-treated and untreated children. Methods: A retrospective descriptive study of patients treated in the last 14 years for IGHD (Group A), in comparison with ISS-treated (Group B) and untreated (Group C) subjects. Results: Group A had 67 males, who showed a height gain of 1.24 SD. Group B had 30 boys, who showed a height gain of 1.47 SD. Group C had 42 boys, who showed an improvement of 0.37 SD. The final heights were −1.52 SD, −1.31 SD, and −2.03 SD, respectively. Group A and C did not reach their target heights (with differences of 0.27 SD and 0.59 SD, respectively). Group B surpassed their target height by 0.29 SD. Conclusions: The final heights of the IGHD and treated ISS are similar. Treated groups were taller than untreated groups.Ana-Belen Ariza-JimenezIsabel Leiva GeaMaria Jose Martinez-Aedo OlleroJuan Pedro Lopez-SigueroMDPI AGarticlegrowth hormone treatmentgrowth hormone deficiencyidiopathic short staturefinal heightMedicineRENJournal of Clinical Medicine, Vol 10, Iss 4988, p 4988 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
growth hormone treatment growth hormone deficiency idiopathic short stature final height Medicine R |
spellingShingle |
growth hormone treatment growth hormone deficiency idiopathic short stature final height Medicine R Ana-Belen Ariza-Jimenez Isabel Leiva Gea Maria Jose Martinez-Aedo Ollero Juan Pedro Lopez-Siguero Isolated Growth Hormone Deficiency and Idiopathic Short Stature: Comparative Efficiency after Growth Hormone Treatment up to Adult Height |
description |
Introduction: Treatment with growth hormone (GH) is not approved for idiopathic short stature (ISS) in Europe. Objectives: To compare the growth of children treated with isolated GH deficiency (IGHD) vs. ISS-treated and untreated children. Methods: A retrospective descriptive study of patients treated in the last 14 years for IGHD (Group A), in comparison with ISS-treated (Group B) and untreated (Group C) subjects. Results: Group A had 67 males, who showed a height gain of 1.24 SD. Group B had 30 boys, who showed a height gain of 1.47 SD. Group C had 42 boys, who showed an improvement of 0.37 SD. The final heights were −1.52 SD, −1.31 SD, and −2.03 SD, respectively. Group A and C did not reach their target heights (with differences of 0.27 SD and 0.59 SD, respectively). Group B surpassed their target height by 0.29 SD. Conclusions: The final heights of the IGHD and treated ISS are similar. Treated groups were taller than untreated groups. |
format |
article |
author |
Ana-Belen Ariza-Jimenez Isabel Leiva Gea Maria Jose Martinez-Aedo Ollero Juan Pedro Lopez-Siguero |
author_facet |
Ana-Belen Ariza-Jimenez Isabel Leiva Gea Maria Jose Martinez-Aedo Ollero Juan Pedro Lopez-Siguero |
author_sort |
Ana-Belen Ariza-Jimenez |
title |
Isolated Growth Hormone Deficiency and Idiopathic Short Stature: Comparative Efficiency after Growth Hormone Treatment up to Adult Height |
title_short |
Isolated Growth Hormone Deficiency and Idiopathic Short Stature: Comparative Efficiency after Growth Hormone Treatment up to Adult Height |
title_full |
Isolated Growth Hormone Deficiency and Idiopathic Short Stature: Comparative Efficiency after Growth Hormone Treatment up to Adult Height |
title_fullStr |
Isolated Growth Hormone Deficiency and Idiopathic Short Stature: Comparative Efficiency after Growth Hormone Treatment up to Adult Height |
title_full_unstemmed |
Isolated Growth Hormone Deficiency and Idiopathic Short Stature: Comparative Efficiency after Growth Hormone Treatment up to Adult Height |
title_sort |
isolated growth hormone deficiency and idiopathic short stature: comparative efficiency after growth hormone treatment up to adult height |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/4f881e7366af45fcbb92a7450b616b30 |
work_keys_str_mv |
AT anabelenarizajimenez isolatedgrowthhormonedeficiencyandidiopathicshortstaturecomparativeefficiencyaftergrowthhormonetreatmentuptoadultheight AT isabelleivagea isolatedgrowthhormonedeficiencyandidiopathicshortstaturecomparativeefficiencyaftergrowthhormonetreatmentuptoadultheight AT mariajosemartinezaedoollero isolatedgrowthhormonedeficiencyandidiopathicshortstaturecomparativeefficiencyaftergrowthhormonetreatmentuptoadultheight AT juanpedrolopezsiguero isolatedgrowthhormonedeficiencyandidiopathicshortstaturecomparativeefficiencyaftergrowthhormonetreatmentuptoadultheight |
_version_ |
1718432062476648448 |